Mediwound ltd. announces proposed public offering of ordinary shares
Yavne, israel, march 02, 2022 (globe newswire) -- mediwound ltd. (nasdaq: mdwd) (“mediwound”), a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration, today announced that it intends to offer its ordinary shares for sale in an underwritten public offering. all of the ordinary shares are being offered by mediwound. in addition, mediwound intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the number of ordinary shares sold in connection with the offering. the offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.